Drug Profile


Alternative Names: Antisedan; MPV 1248

Latest Information Update: 20 Oct 2003

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Orion
  • Developer Nonindustrial source; Orion
  • Class Antidepressants; Antihyperglycaemics; Antihypertensives; Drug withdrawal therapies
  • Mechanism of Action Alpha 2 adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Alcoholism; Major depressive disorder; Male sexual dysfunction; Parkinson's disease

Most Recent Events

  • 20 Oct 2003 Discontinued - Phase-I for Alcoholism in USA (IV)
  • 20 Oct 2003 Discontinued for Male sexual dysfunction in Finland (IV)
  • 25 Mar 1998 Discontinued-II for Depression in Finland (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top